ArticleJAMA internal medicine2019
Pharmaceutical Company Payments to Executive Board Members of Professional Medical Associations in Japan.
Article in JAMA internal medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Industry-Reported Financial Relationships Among American Ophthalmology Society Board Members.Clinical & experimental ophthalmology · 2026Article
- Pharmaceutical Industry Payments to Professional Medical Societies in Japan.Journal of general internal medicine · 2024Article
- Association between Conflicts of Interest Disclosure and Quality of Clinical Practice Guidelines in Japan: A Meta-Epidemiological Study.Journal of personalized medicine · 2023Article
- Article
- Evaluation of non-research payments from pharmaceutical companies to urologists in Japan between 2016 and 2019.International urogynecology journal · 2023Article
- Pharmaceutical payments to Japanese board-certified dermatologists: a 4-year retrospective analysis of personal payments from pharmaceutical companies between 2016 and 2019.Scientific reports · 2023Article
- Cross-sectional analysis of pharmaceutical payments to Japanese board-certified gastroenterologists between 2016 and 2019.BMJ open · 2023Article
- International comparison of pharmaceutical industry payment disclosures in the UK and Japan: implications for self-regulation, public regulation, and transparency.Globalization and health · 2023Article
- Pharmaceutical Payments to Japanese Board-Certified Infectious Disease Specialists: A Four-Year Retrospective Analysis of Payments from 92 Pharmaceutical Companies between 2016 and 2019.International journal of environmental research and public health · 2022Article
- Awareness and Perceptions among Members of a Japanese Cancer Patient Advocacy Group Concerning the Financial Relationships between the Pharmaceutical Industry and Physicians.International journal of environmental research and public health · 2022Article
- The Impact of Synchronous Telehealth Services With a Digital Platform on Day-by-Day Home Blood Pressure Variability in Patients with Cardiovascular Diseases: Retrospective Cohort Study.Journal of medical Internet research · 2022Article
- Financial conflicts of interest between pharmaceutical companies and the authors of urology clinical practice guidelines in Japan.International urogynecology journal · 2021Article
- Financial ties between leaders of influential US professional medical associations and industry: cross sectional study.BMJ (Clinical research ed.) · 2020Article
- Pharmaceutical company payments to dermatology Clinical Practice Guideline authors in Japan.PloS one · 2020Article
- Are Pharmaceutical Company Payments Incentivising Malpractice in Japanese Physicians?International journal of health policy and management · 2019Article
- Pharmaceutical payments to certified oncology specialists in Japan in 2016: a retrospective observational cross-sectional analysis.BMJ open · 2019Observational
- Evaluation of Pharmaceutical Company Payments and Conflict of Interest Disclosures Among Oncology Clinical Practice Guideline Authors in Japan.JAMA network open · 2019Article
- Pharmaceutical Payments to Japanese Board-Certified Head and Neck Surgeons Between 2016 and 2019.OTO openArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.